BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 30891028)

  • 21. Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.
    Touw IP; Beekman R
    Haematologica; 2013 Oct; 98(10):1490-2. PubMed ID: 24091926
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe congenital neutropenias.
    Skokowa J; Dale DC; Touw IP; Zeidler C; Welte K
    Nat Rev Dis Primers; 2017 Jun; 3():17032. PubMed ID: 28593997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
    Dannenmann B; Klimiankou M; Oswald B; Solovyeva A; Mardan J; Nasri M; Ritter M; Zahabi A; Arreba-Tutusaus P; Mir P; Stein F; Kandabarau S; Lachmann N; Moritz T; Morishima T; Konantz M; Lengerke C; Ripperger T; Steinemann D; Erlacher M; Niemeyer CM; Zeidler C; Welte K; Skokowa J
    Cell Stem Cell; 2021 May; 28(5):906-922.e6. PubMed ID: 33894142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel
    Connelly JA; Mody RJ; Wu YM; Robinson DR; Lonigro RJ; Vats P; Rabban E; Anderson B; Walkovich K
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29572239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
    Beekman R; Valkhof MG; Sanders MA; van Strien PM; Haanstra JR; Broeders L; Geertsma-Kleinekoort WM; Veerman AJ; Valk PJ; Verhaak RG; Löwenberg B; Touw IP
    Blood; 2012 May; 119(22):5071-7. PubMed ID: 22371884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G-CSF receptor mutations in patients with congenital neutropenia.
    Germeshausen M; Skokowa J; Ballmaier M; Zeidler C; Welte K
    Curr Opin Hematol; 2008 Jul; 15(4):332-7. PubMed ID: 18536571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
    Tidow N; Pilz C; Teichmann B; Müller-Brechlin A; Germeshausen M; Kasper B; Rauprich P; Sykora KW; Welte K
    Blood; 1997 Apr; 89(7):2369-75. PubMed ID: 9116280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.
    Zeidler C; Germeshausen M; Klein C; Welte K
    Br J Haematol; 2009 Feb; 144(4):459-67. PubMed ID: 19120359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis and clinical picture of severe congenital neutropenia in Israel.
    Lebel A; Yacobovich J; Krasnov T; Koren A; Levin C; Kaplinsky C; Ravel-Vilk S; Laor R; Attias D; Ben Barak A; Shtager D; Stein J; Kuperman A; Miskin H; Dgany O; Giri N; Alter BP; Tamary H
    Pediatr Blood Cancer; 2015 Jan; 62(1):103-8. PubMed ID: 25284454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21).
    Sano H; Ohki K; Park MJ; Shiba N; Hara Y; Sotomatsu M; Tomizawa D; Taga T; Kiyokawa N; Tawa A; Horibe K; Adachi S; Hayashi Y
    Br J Haematol; 2015 Aug; 170(3):391-7. PubMed ID: 25858548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
    N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
    Freedman MH; Alter BP
    Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
    Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
    Kalra R; Dale D; Freedman M; Bonilla MA; Weinblatt M; Ganser A; Bowman P; Abish S; Priest J; Oseas RS; Olson K; Paderanga D; Shannon K
    Blood; 1995 Dec; 86(12):4579-86. PubMed ID: 8541548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital neutropenia: From lab bench to clinic bedside and back.
    Dobrewa W; Bielska M; Bąbol-Pokora K; Janczar S; Młynarski W
    Mutat Res Rev Mutat Res; 2024; 793():108476. PubMed ID: 37989463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
    Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
    Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
    Yılmaz Karapınar D; Patıroğlu T; Metin A; Çalışkan Ü; Celkan T; Yılmaz B; Karakaş Z; Karapınar TH; Akıncı B; Özkınay F; Onay H; Yeşilipek MA; Akar HH; Tüysüz G; Tokgöz H; Özdemir GN; Aslan Kıykım A; Karaman S; Kılınç Y; Oymak Y; Küpesiz A; Olcay L; Keskin Yıldırım Z; Aydoğan G; Gökçe M; İleri T; Aral YZ; Bay A; Atabay B; Kaya Z; Söker M; Özdemir Karadaş N; Özbek U; Özsait Selçuk B; Özdemir HH; Uygun V; Tezcan Karasu G; Yılmaz Ş
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27923. PubMed ID: 31321910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic mutations and clonal hematopoiesis in congenital neutropenia.
    Xia J; Miller CA; Baty J; Ramesh A; Jotte MRM; Fulton RS; Vogel TP; Cooper MA; Walkovich KJ; Makaryan V; Bolyard AA; Dinauer MC; Wilson DB; Vlachos A; Myers KC; Rothbaum RJ; Bertuch AA; Dale DC; Shimamura A; Boxer LA; Link DC
    Blood; 2018 Jan; 131(4):408-416. PubMed ID: 29092827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias.
    Germeshausen M; Ballmaier M; Welte K
    Ann N Y Acad Sci; 2001 Jun; 938():305-20; discussion 320-1. PubMed ID: 11458519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe congenital neutropenia.
    Welte K; Zeidler C
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):307-20. PubMed ID: 19327585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.